Hanall Biopharma Co., Ltd. (KRX:009420)

South Korea · Delayed Price · Currency is KRW

50,500

-2,100 (-3.99%)

At close: Jan 9, 2026

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2003 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2003 - 2019
Pharmaceutical	138.94B	Log In	Log In	Log In	Log In	Upgrade
Pharmaceutical Growth	2.99%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2003 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2003 - 2019
South Korea	138.94B	Log In	Log In	Log In	Log In	Upgrade
South Korea Growth	3.04%	Log In	Log In	Log In	Log In	Upgrade
International	-	Log In	Log In	Log In	Log In	Upgrade
International Growth	-	Log In	Log In	Log In	Log In	Upgrade